🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Illinois › Naperville

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Naperville, IL keessatti

Qorannoo 16 Kansara Qara'a Non-Small Cell f Naperville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • Advocate Good Samaritan Hospital, Downers Grove · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Namoota walitti qabaa jiraSadarkaa 3
  • Duly Healthcare ( Site 0158), Lisle · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07554339

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 3
  • Accellacare of Duly, Lisle · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Namoota walitti qabaa jiraSadarkaa 3
  • Accellacare of Duly ( Site 4005), Lisle · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06312137

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Namoota walitti qabaa jiraSadarkaa 3
  • Endeavor Health, Naperville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06758401

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Duly Health and Care - Lisle, Lisle · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07195695

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04302025

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06500481

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06686771

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Namoota walitti qabaa jiraSadarkaa 3
  • Edward Cancer Center, Naperville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT06216301

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
  • Advocate Good Samaritan Hospital, Downers Grove · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
  • Advocate Good Samaritan Hospital, Downers Grove · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
  • Advocate Good Samaritan Hospital, Downers Grove · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern Medicine Cancer Center Warrenville, Warrenville · Miili 3 fagaatti
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Advocate Good Samaritan Hospital, Downers Grove · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo Naperville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.